Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Olympus inhales Spiration

This article was originally published in The Gray Sheet

Executive Summary

Pulmonary device maker Spiration is acquired by bronchoscope maker Olympus for undisclosed terms in a deal announced June 25. Spiration's IBV removable bronchial valve implant gained FDA humanitarian device exemption (HDE) approval in 2008 to treat prolonged air leaks following certain lung surgeries (1"The Gray Sheet" Nov. 3, 2008). A pivotal study of the device for severe emphysema is ongoing. "We will take advantage of the synergies of the two companies in our development of next-generation endoscopic respiratory products," Olympus said

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029060

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel